Amicus Therapeutics today announced the issuance on March 10, 2009 of United States Patent No. 7,501,439, titled "Tartrate Salt of Isofagomine and Methods of Use." The patent covers the tartrate salt form of isofagomine, the active ingredient in the Company's investigational drug Plicera (afegostat tartrate), and its use for the treatment of Gaucher disease. The patent will expire in 2027.
The details can be read here.
No comments:
Post a Comment